Indegene IPO Details Today: Indegene IPO is Open on 6 May 2024 and Close on 8 May 2024. Indegene IPO to Raise 40,746,891 shares (Approx ₹1,841.76 Cr) via IPO. The Fresh Issue of 40,746,891 shares (Approx ₹1,841.76 Cr).
We are a “digital-first” commercialization company focused exclusively on the global life sciences industry. Our solutions enable biopharmaceutical, emerging biotech and medical devices companies develop products, launch them in the market, and drive sales through their life cycle in a more effective, efficient and modern manner.
We achieve this by combining over two decades of healthcare domain expertise and fit-for-purpose technology. Our portfolio of solutions cover all aspects of commercial, medical, regulatory and R&D operations of life sciences companies.
Life sciences enterprises require a talent pool with in-depth domain expertise on the journey of a drug or medical device from the research lab to the market to organize and analyze scientific and clinical data, navigate the regulatory landscape and the ethical guidelines within which the industry operates, and to develop the requisite medical content for healthcare professionals, patients, and payers. Scarcity of such talent is a major hindrance in operations. At the same time, drug pricing caps create margin pressures on biopharmaceutical companies, thus risking the overall profitability of the industry and consequently, operationsspend. While there are such talent gaps and margin pressures, life sciences companies are placing greater emphasis on digital innovation and enterprise-wide transformation initiatives to improve operational efficiencies.
Indegene IPO Date & Price Band Details
IPO Open Date
6 May 2024
IPO Close Date
8 May 2024
IPO Size
40,746,891 shares (Approx ₹1,841.76 Cr)
Fresh Issue
40,746,891 shares (Approx ₹1,841.76 Cr)
Lot Size
33 Shares
IPO Face Value
₹10 Per Equity Share"
IPO Price Band
₹430 - ₹452 Per Every Share
Employee Discount
₹30 per Share
IPO Listing On
BSE NSE
IPO Retail Quota
35%
IPO QIB Quota
50%
IPO NII Quota
15%
DRHP Draft
Click Here
Anchor Investor
Click Here
Indegene IPO Market Lot Details
Application
Lot Size
Shares
Amount
Retail Minimum
1
33
₹14,916
Retail Maximum
13
429
₹193,908
S-HNI Minimum
14
462
₹208,824
S-HNI Maximum
67
2,211
₹999,372
B-HNI Minimum
68
2,244
₹1,014,288
Object of the Issue
- Repayment/prepaymentof indebtedness of one of our Subsidiaries, ILSL Holdings, Inc.
- Funding the capital expenditure requirements of our Company and our Material Subsidiary, Indegene,Inc.
- Payment of consideration towards acquisition of additional shares in DT Associates Limitedby ILSL Holdings,Inc., a Subsidiary.
- General corporate purposes and inorganic growth.
Indegene IPO Allotment & Listing Date (Details)
IPO Open Date
6 May 2024
IPO Close Date
8 May 2024
Basis of Allotment
9 May 2024
Refunds
10 May 2024
Credit to Demat Account
10 May 2024
IPO Listing Date
13 May 2024
Indegene Anchor Investors
Indegene IPO Raise Fund Approx Rs. 548.78 Cr. from Anchor Investors. Indegene IPO bid Date Starts from 3 May 2024. Indegene IPO Anchor Investors List.
| Bid Date | 3 May 2024 |
|---|---|
| Shared Offered | 12,141,102 Equity Shares |
| Anchor Portion Size (In Cr.) | 5,48,77,78,104 |
| Anchor Lock End Date for 50% Shares (30 days) | 8 June 2024 |
| Anchor Lock End Date for Remaining Shares (90 days) | 7 August 2024 |
Indegene Financial Reports
₹ in Crores
Year
Revenue
Expense
PAT
Dec 2023
₹1969.75
₹1644.64
₹241.90
2023
₹2364.10
₹2001.05
₹266.10
2022
₹1690.50
₹1417.10
₹162.82
2021
₹996.92
₹768.25
₹149.41
Our Company Promoters-
N/A
Indegene Comparison Listed Industry Peers Group
N/A
Qualitative Factors
- Domain expertise in healthcare.
- Robust digital capabilities and in-house developed technology portfolio.
- Track record of establishing long-standing client relationships.
- Global delivery model.
- Experienced management and motivated talent pool supported by marquee investors.
- Track record of creating value through acquisitions.
Comparison of Accounting Ratios with Peer Group Companies.
N/A
Indegene Company Contact Details
Aspen Block G4, 3rdFloor
Manyata Embassy Business Park
Outer Ring Road, Nagawara
Bengaluru-560045
Karnataka India
Email:compliance.officer@indegene.com
Tel:+91 80 4674 4567
Website: www.indegene.com
Indegene IPO Registar
Link Intime India Private Limited
C-101, 1stFloor, 247 Park,
L.B.S. Marg,
Vikhroli West,Mumbai 400 083,
Maharashtra, India
Tel: +91 810811 4949
E-mail: indegene.ipo@linkintime.co.in
Investor grievance email: indegene.ipo@linkintime.co.in
Website:www.linkintime.co.in
Contact person: Shanti Gopalkrishnan
